Company Filing History:
Years Active: 2019
Title: Amparo Galán Ortega: Innovator in Heart Failure Prognosis
Introduction
Amparo Galán Ortega is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of medical research, particularly in the area of heart failure. Her innovative work has led to the development of a patented method that aids in determining the prognosis of patients suffering from heart failure.
Latest Patents
Amparo holds a patent for her invention titled "Neprilysin as heart failure prognostic marker." This invention provides an in vitro method for determining the prognosis in a patient suffering from heart failure. The method involves determining the level of soluble neprilysin (NEP) in a test sample from the patient. This advancement has the potential to improve patient outcomes by enabling more accurate prognostic assessments.
Career Highlights
Amparo Galán Ortega is affiliated with the Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, where she conducts her research. Her dedication to advancing medical science is evident in her innovative approaches and commitment to improving patient care.
Collaborations
Amparo has collaborated with notable colleagues in her field, including Antoni Bayes Genis and Josep Lupón Rosés. These partnerships have further enriched her research and contributed to the development of her groundbreaking patent.
Conclusion
Amparo Galán Ortega's work exemplifies the impact of innovation in the medical field, particularly in the prognosis of heart failure. Her contributions are paving the way for improved patient care and outcomes.